Application 218792
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | UPADACITINIB | UPADACITINIB | TABLET, EXTENDED RELEASE | 30MG | No | No |
| 003 | UPADACITINIB | UPADACITINIB | TABLET, EXTENDED RELEASE | 15MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rinvoq | UPADACITINIB | AbbVie Inc. | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | UPADACITINIB |